Yahoo! Finance: GNVC News

[$$] Biotech Stock Mailbag: Cardium Therapeutics (at RealMoney by TheStreet.com)

Fri, 13 Nov 2009 10:00:29 Etc/GMT

GENVEC INC Financials (EDGAR Online Financials)

Wed, 11 Nov 2009 14:04:55 Etc/GMT

New Star Analyst Rankings for GenVec, Inc. (StarMine)

Sun, 8 Nov 2009 14:19:55 Etc/GMT

GENVEC INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)

Fri, 6 Nov 2009 19:01:39 Etc/GMT

GenVec, Inc. Earnings Call scheduled for 10:00 am ET today (CCBN)

Fri, 6 Nov 2009 15:00:00 Etc/GMT

GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online)

Thu, 5 Nov 2009 21:48:18 Etc/GMT

GenVec Reports Third Quarter 2009 Financial Results (PR Newswire)

Thu, 5 Nov 2009 21:17:00 Etc/GMT

GenVec, Inc. today announced its financial results for the third quarter ended September 30, 2009. GenVec reported a net loss of $3.6 million for the three months ended September 30, 2009 compared to a net loss of $6.8 million in the comparable quarter of 2008.

GenVec Signs New Contract to Support HIV and Influenza Vaccine Development (PR Newswire)

Thu, 5 Nov 2009 12:53:00 Etc/GMT

GenVec, Inc. announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health .

Q3 2009 GenVec, Inc. Earnings Release - After Market Close (CCBN)

Thu, 5 Nov 2009 12:07:20 Etc/GMT

GenVec’s TNFerade wins regulatory incentives (at bizjournals.com)

Wed, 4 Nov 2009 16:05:19 Etc/GMT

FDA Grants Orphan Drug Designation for TNFerade(TM) (PR Newswire)

Wed, 4 Nov 2009 12:44:00 Etc/GMT

GenVec to Present at Merriman Curhan Ford's Investor Summit 2009 (PR Newswire)

Tue, 3 Nov 2009 13:47:00 Etc/GMT

Today GenVec, Inc. announced that Paul H. Fischer, Ph.D., President and CEO, will present a company overview highlighting recent developments at the Merriman Curhan Ford's 6th Annual Investor Summit on Tuesday, November 10, 2009 at 9:20 am EST at Sofitel Hotel in New York, NY.

GenVec Announces Third Quarter 2009 Results Conference Call (PR Newswire)

Wed, 28 Oct 2009 11:47:00 Etc/GMT

GenVec, Inc. announced that it will release financial results for the third quarter ended September 30, 2009 on Thursday, November 5, 2009 after market close. GenVec will hold a conference call at 10:00 a.m.

GenVec to Present at the BIO Investor Forum (PR Newswire)

Thu, 22 Oct 2009 12:17:00 Etc/GMT

Today GenVec, Inc. announced that Paul H. Fischer, Ph.D., President and CEO, will present a company overview highlighting recent developments at the BIO Investor Forum on Thursday, October 29, 2009 at 12:00 pm PST at The Palace Hotel in San Francisco, CA.

CEO Interview: GenVec, Inc. - Dr. Paul H. Fischer (Wall Street Transcript)

Tue, 20 Oct 2009 20:08:00 Etc/GMT

67 WALL STREET, New York - October 20, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70-page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

CEO Interview: CombiMatrix Corporation - Dr. Amit Kumar (Wall Street Transcript)

Tue, 20 Oct 2009 17:12:00 Etc/GMT

StockPreacher.com Issues Trading Outlook for GenVec Inc. (GlobeNewswire)

Fri, 16 Oct 2009 10:50:00 Etc/GMT

DALLAS -- StockPreacher.com announces an investment report featuring anti-cancer drug developer GenVec Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.

Early Movers: Pump Up the Volume (at TheStreet.com)

Fri, 2 Oct 2009 12:32:59 Etc/GMT

Coverage initiated on Genvec by Merriman (Briefing.com)

Fri, 2 Oct 2009 11:07:24 Etc/GMT

GENVEC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf (EDGAR Online)

Wed, 16 Sep 2009 20:57:18 Etc/GMT